MedPath

Heart Revascularisation Trial - UK

Not Applicable
Completed
Conditions
Topic: Cardiovascular
Subtopic: Cardiovascular (all Subtopics)
Disease: Cardiovascular
Circulatory System
Stress-induced ischaemia
Registration Number
ISRCTN66339600
Lead Sponsor
Hull and East Yorkshire Hospitals NHS Trust (UK)
Brief Summary

2011 results in: https://www.ncbi.nlm.nih.gov/pubmed/21156659 (added 13/06/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
138
Inclusion Criteria

1. Heart failure (in the investigators opinion) requiring chronic diuretic therapy
2. Coronary disease as the cause of heart failure as evidenced by a history of previous myocardial infarction, previous revascularisation or previous angiography
3. Left ventricular systolic dysfunction (ejection fraction less than 35%)
4. Stress-induced myocardial ischaemia or evidence of myocardial hibernation/stunning affecting five or more left ventricular segments in a 16-segment model
5. Male and female, lower age limit of 18 years

Exclusion Criteria

1. Inability to give written informed consent. No age limits are stipulated but patients will have to be over 18 years to give consent and some patients may be considered too frail to survive surgery and would be excluded.
2. Patients who are not candidates for coronary artery bypass graft (CABG) surgery because of frailty or serious co-morbidity, e.g., severe lung disease, metastatic carcinoma. N.B. Some patients will be candidates for percutaneous transluminal coronary angioplasty (PTCA) but prior to randomisation (i.e. prior to doing an angiogram for study purposes) the investigator should be willing to send the patient to CABG surgery in case that is the preferred mode of revascularisation.
3. Unstable angina, myocardial infarction or stroke within the preceding 2 months
4. Patients being considered for revascularisation for the relief of chest pain (angina) or for valve surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath